Details About Generic Salt ::  Methyser

Main Medicine Class:: Analgesic,Migraine   

(METH-ih-SIR-jide MAL-ee-ate)

Sansert

Class: Analgesic/Migraine

Drugs Class ::

 Action Semisynthetic ergot derivative possessing no intrinsic vasoconstrictor activity; believed to work by antagonizing effects of serotonin in lowering pain threshold.

Indications for Drugs ::

 Indications Prevention or reduction of intensity of severe and frequent (once weekly or more) vascular headaches; prophylaxis of vascular headache. Not for management of acute attack.

Drug Dose ::

 Route/Dosage

ADULTS: PO 4–8 mg daily with meals. There must be drug-free interval of 3–4 wk after 6 mo of treatment.

Contraindication ::

 Contraindications Pregnancy; peripheral vascular disease; severe arteriosclerosis; severe hypertension; coronary artery disease; phlebitis or cellulitis in lower limbs; ulmonary disease; collagen disease or fibrotic processes; impaired liver or renal function; valvular heart disease; debilitated states; serious infections.

Drug Precautions ::

 Precautions

Pregnancy: Contraindicated in pregnancy due to oxytocic properties. Lactation: Excreted in breast milk. Children: Not recommended for children. Fibrosis: Long-term methylsergide therapy may cause retroperitoneal fibrosis, pleuropulmonary fibrosis and fibrotic complications within cardiovascular system. These may be reversible. This drug should be reserved for prophylaxis of frequent, severe or uncontrollable vascular headaches under close supervision. To reduce fibrotic risks, continuous use should not exceed 6 mo. Reduce dosage gradually over 2–3 wk to avoid “rebound headache.” Provide 3–4 wk drug-free interval between each 6-mo course of therapy. Tartrazine sensitivity: Contains tartrazine, which may cause allergic reactions in susceptible people.

Drug Side Effects ::

 Adverse Reactions

CV: Encroachment of retroperitoneal fibrosis on aorta, inferior vena cava and common iliac branches may cause vascular insufficiency of lower limbs; fibrotic thickening of cardiac valves; murmurs; bruits; arterial vasoconstriction causing chest pain; coldness, numbness or pain in extremities; diminished or absent pulse; ischemic tissue damage; orthostatic hypotension; tachycardia; eripheral edema. CNS: Insomnia; drowsiness; mild euphoria; dizziness; ataxia; weakness; lightheadedness; yperesthesia; hallucinatory dissociation; parasthesias. DERM: Facial flush; telangiectasia; rash; initial increased hair loss. GI: Nausea; vomiting; diarrhea; heartburn; abdominal pain; constipation. HEMA: Neutropenia; eosinophilia. RESP: Pleuropulmonary fibrosis. OTHER: Arthralgia; myalgia; weight loss.

Drug Mode of Action ::  

 Action Semisynthetic ergot derivative possessing no intrinsic vasoconstrictor activity; believed to work by antagonizing effects of serotonin in lowering pain threshold.

Drug Interactions ::

 Interactions

Beta blockers: May result in peripheral ischemia, manifested by cold extremities with possible peripheral gangrene.

Drug Assesment ::

 Assessment/Interventions

• Obtain patient history, including drug history and any known allergies. Note tartrazine sensitivity.
• Obtain cardiac and renal function studies, blood count and sedimentation rate before administration and monitor throughout therapy.
• Palpate for diminished or absent peripheral pulses, changes in extremity color/temperature or peripheral edema throughout prolonged therapy.
• Implement appropriate safety precautions, as patient may be at risk for falls due to insomnia, lightheadedness, hyperesthesia or hallucinatory experiences.
• Notify physician of orthostatic hypotension or tachycardia, chest or flank pain, leg cramps or shortness of breath.

Drug Storage/Management ::

 Administration/Storage

• Administer as supplied; do not crush.
• Give with meals.

Drug Notes ::

 Patient/Family Education

• Caution patient that this medication must not be taken during pregnancy or when pregnancy is possible. Advise patient to use reliable form of birth control while taking this drug.
• Explain that medication can be taken with food or milk if GI upset occurs.
• Tell patient that medication may cause drowsiness and to use caution while driving or performing other tasks requiring mental alertness, coordination, dexterity.
• Instruct patient or family member to check regularly for cold or numb extremities.
• Advise patient to report these symptoms to physician immediately: eg cramps, chest pain, flank pain, shortness of breath or painful urination.
• Caution patient to avoid sudden position changes to prevent orthostatic hypotension.
• Tell patient to consult physician after 6 mo of therapy regarding tapering of regimen.
• Explain that medication should not be discontinued abruptly; which may cause rebound headache.
• Educate patient to report rapid weight gain and to check for peripheral edema. Explain benefits of low salt, reduced calorie diet if necessary.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.